Liquidia Corporation $LQDA Shares Sold by Mirabella Financial Services LLP

Mirabella Financial Services LLP decreased its position in Liquidia Corporation (NASDAQ:LQDA) by 45.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 247,405 shares of the company’s stock after selling 203,827 shares during the quarter. Mirabella Financial Services LLP owned 0.28% of Liquidia worth $5,626,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in LQDA. FNY Investment Advisers LLC acquired a new stake in shares of Liquidia in the third quarter valued at $34,000. Tudor Investment Corp ET AL acquired a new position in Liquidia during the 3rd quarter worth about $1,536,000. Caxton Associates LLP acquired a new position in Liquidia during the 3rd quarter worth about $389,000. TCG Crossover Management LLC purchased a new position in Liquidia during the 3rd quarter valued at about $38,887,000. Finally, Voloridge Investment Management LLC acquired a new position in Liquidia in the 3rd quarter valued at about $12,571,000. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Liquidia

In other Liquidia news, insider Rajeev Saggar sold 21,142 shares of the firm’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $37.43, for a total value of $791,345.06. Following the sale, the insider directly owned 176,883 shares in the company, valued at $6,620,730.69. This trade represents a 10.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel Russell Schundler sold 27,289 shares of the firm’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $37.43, for a total value of $1,021,427.27. Following the completion of the sale, the general counsel owned 579,394 shares in the company, valued at approximately $21,686,717.42. This represents a 4.50% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 212,534 shares of company stock worth $7,964,719. 26.50% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

LQDA has been the topic of a number of recent research reports. Raymond James Financial reiterated a “strong-buy” rating on shares of Liquidia in a research note on Thursday, March 5th. Jefferies Financial Group lifted their price objective on shares of Liquidia from $45.00 to $55.00 and gave the company a “buy” rating in a report on Tuesday, January 13th. Wall Street Zen raised shares of Liquidia from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. Oppenheimer upped their price objective on Liquidia from $16.00 to $19.00 and gave the stock an “underperform” rating in a research report on Thursday, March 12th. Finally, BTIG Research increased their price objective on Liquidia from $49.00 to $50.00 and gave the company a “buy” rating in a research note on Thursday, March 5th. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $42.67.

Liquidia Stock Down 0.6%

Shares of NASDAQ:LQDA opened at $36.63 on Thursday. The firm’s 50 day moving average price is $37.77 and its 200 day moving average price is $31.47. The stock has a market cap of $3.23 billion, a price-to-earnings ratio of -44.13 and a beta of 0.52. Liquidia Corporation has a fifty-two week low of $11.26 and a fifty-two week high of $46.67. The company has a quick ratio of 1.84, a current ratio of 2.01 and a debt-to-equity ratio of 2.97.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Thursday, March 5th. The company reported $0.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.07. Liquidia had a negative net margin of 43.53% and a negative return on equity of 209.33%. The company had revenue of $92.02 million during the quarter, compared to the consensus estimate of $87.49 million. The business’s quarterly revenue was up 3072.4% compared to the same quarter last year. As a group, equities research analysts predict that Liquidia Corporation will post -1.51 earnings per share for the current fiscal year.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).